|
LARP4B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.859000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.451000E-01 |
| Normal-vs-Stage2 |
6.854600E-01 |
| Normal-vs-Stage3 |
7.927000E-01 |
| Normal-vs-Stage4 |
6.818400E-01 |
| Stage1-vs-Stage2 |
9.058600E-01 |
| Stage1-vs-Stage3 |
4.124000E-01 |
| Stage1-vs-Stage4 |
4.076600E-01 |
| Stage2-vs-Stage3 |
6.261600E-01 |
| Stage2-vs-Stage4 |
5.209200E-01 |
| Stage3-vs-Stage4 |
8.204400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.227200E-01 |
| Normal-vs-AfricanAmerican |
7.257200E-01 |
| Normal-vs-Asian |
3.176400E-01 |
| Caucasian-vs-AfricanAmerican |
8.999800E-01 |
| Caucasian-vs-Asian |
2.880800E-01 |
| AfricanAmerican-vs-Asian |
2.860600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.695790E-01 |
| Normal-vs-Female |
5.163900E-02 |
| Male-vs-Female |
4.104100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.803200E-01 |
| Normal-vs-Extreme_Weight |
4.556000E-02 |
| Normal-vs-Obese |
5.156000E-01 |
| Normal-vs-Extreme_Obese |
1.150030E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.797430E-01 |
| Normal_Weight-vs-Obese |
7.580400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.779200E-01 |
| Extreme_Weight-vs-Obese |
2.417900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.797200E-01 |
| Obese-vs-Extreme_Obese |
1.186420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.812390E-02 |
| Normal-vs-Age(41-60Yrs) |
3.384400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.109770E-01 |
| Normal-vs-Age(81-100Yrs) |
2.894200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.552570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.839500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.352000E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.437820E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.602120E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.546000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.000200E-01 |
| Normal-VS-Type2 PRCC |
1.740210E-02 |
| Normal-VS-KIRP CIMP |
7.082200E-02 |
| Normal-VS-Unclassified PRCC |
9.060600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.941600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.764200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.376400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.501400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.152300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.529600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.517700E-02 |
| Normal-vs-N1 |
4.714600E-01 |
| Normal-vs-N2 |
7.503200E-01 |
| N0-vs-N1 |
2.919500E-02 |
| N0-vs-N2 |
1.952250E-01 |
| N1-vs-N2 |
8.960400E-01 |
|
|
